Treatment of Breast Disease Flashcards

1
Q

breast cancer affects how many women?

A

1 in 8

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is a carcinoma in situ?

A

cells have malignant changes but are contained within the basement membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

discuss the finding and progression of DCIS

A

This is the commonest type of breast cancer. 3% are symptomatic and 17% of the cancers detected at screening. If you follow the patient up without doing anything there is a 2% of invasion in the same area of the same breast.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

discuss lobular carcinoma in situ

A

0.5% are symptomatic and 1% for cancers found at screening. If you follow the patient up without doing anything there is a 2% of invasion but it can happen anywhere in either breast.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is invasive carcinoma?

A

cells have malignant changes and have penetrated the basement membrane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how can you diagnose breast ca?

A
  • History and clinical examination
  • Mammography
  • Ultrasonography
  • Magnetic resonance mammography
  • Cytology (FNAC)
  • Core biopsy
  • Image guided cytology or core biopsy
  • Open (surgical) biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

risk factors for breast ca

A
Anything that exposes the breast to radiation increases the risk of breast cancer:
• Age
• Geographical variation (more common in Western world)
• Age at menarche and menopause
• Age at first pregnancy
o Older = more likely
• Family history
• Previous benign breast disease
• Cancer in the other breast
• Radiation
o Hodgkin’s disease is treated with radiation to the chest and as a result 1 in 3 will
develop breast cancer
• Lifestyle
o High fat – produces oestrogen
o Alcohol – exposes breast to acetyl aldehyde
• Oral contraceptive
o Disappears within 5 years
• HRT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

signs and symptoms of breast ca

A

• Lump or thickening in the breast, often painless
o Most common
• Discharge or bleeding
• Change in size or contours of breast
• Change in colour or appearance of areola
• Redness or pitting over the skin of the breast
o Peau d’orange
o Inflammatory breast Ca, often misdiagnosed as an abscess or an infection and associated with a poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how can you assess the severity of breast ca

A
  • Hb, FBC, U+Es, LFTs
  • CXR
  • Isotope bone scan
  • Others as clinically indicated
  • No reliable tumour markers – none sensitive or specific enough
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

staging of breast ca

A
• Tumour (T)
o T1 – <2cm
o T2 – 2-5cm
o T3 – >5cm
o T4 – fixed to skin or muscle (poor prognosis)
• Nodes (N)
o N0 – node
o N1 – nodes in axilla
• Metastases (M)
o M0 – none
o M1 - metastases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

treatment of breast ca

A
• Primary breast cancer
o Local control, eradicate disease
• Regional tumour-draining nodes
o Regional control, staging, eradicate disease
• Micrometastases
o Eradicate disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

breast ca surgery

A
  1. Breast conservation
    a. Wide local excision, quadrantectomy or segmentectomy
    b. Tumour + 1mm of healthy breast tissue
  2. Mastectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

when is breast conservation surgery suitable?

A
Trials have shown that for tumours less than 4cm survival for breast conservation is equal to mastectomy
Patients suitable for breast
conservation:
• Tumour size <4cm (clinically)
• Breast/tumour size ration
• Suitable for radiotherapy
• Single tumours
• Minimal in situ cancer component present
• Patients wish – most important
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

axillary clearance in breast ca

A

If sentinel node is involved or patients have FNAC at clinical which shows malignant cells, then all nodes need to be removed from the axilla. No radiotherapy is given, even if nodes are involved with tumour. There is more morbidity than other types of axillary surgery.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

complications of axillary clearance

A
  • Lymphoedema
  • Sensory disturbance as a result of damage to the intercostobrachial nerve
  • Decrease ROM in the shoulder joint
  • Nerve damage (long thoracic, thoracodorsal, brachial plexus)
  • Vascular damage
  • Radiation-induce sarcoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

treatment of breast micrometastases

A

hormone therapy
chemotherapy
targeted therapies

17
Q

hormone therapy for breast micrometastates

A

a. oestrogen receptors must be present
b. Premenopausal
i. Tamoxifen for 5 years (oestrogen receptor blocker)
c. Postmenopausal
i. Tamoxifen for 5 years if excellent prognosis
ii. Aromatase inhibitor for 5 years if poorer prognosis
1. Anastrozole is a better drug
2. Aromatase converts testosterone into oestrogen. 5-10% of oestrogen comes from this way. This will reduce oestrogen but not completely
iii. In Scotland if the prognosis is intermediate – tamoxifen for 2 years and aromatase inhibitor for 3 years

18
Q

chemotherapy for breast micrometastases

A

a. Better effects if <50
b. Node positive
c. Grade 3 cancers
d. Toxicity, morbidity, mortality

19
Q

targeted therapies for breast micrometastases

A

Anti-Her2 therapy – Trastuzumab (Herceptin)

i. Monoclonal antibody against Her2 receptor
ii. Given to patients with over-expression of Her2 and chemotherapy
iii. 50% decrease in risk of recurrence
iv. 33% increase in 3-year survival

20
Q

current follow up of breast ca

A

Many different protocols as poor evidence base. Currently clinical examination 6 monthly for 5 years. Yearly after that and discharge after 5 or 10 years. Mammogram of breasts at yearly intervals for 10 years.